Buyer’s Guide: Collateral Management & OTC Derivatives Processing Solutions 2019
In 2019, the collateral management and OTC derivatives processing vendor solutions space is dominated by two questions from a Tier I and Tier II investment bank selection process perspective:
· Vendor Selection & Total Cost of Ownership – Which vendor solution is capable of offering a ‘true,’ front-to-back, single-platform experience at an enterprise-wide level, thus negating the need for costly, labour-intensive deployments and implementations of two or more systems? and
· Modularity & Buy-and-Build – From a product or technology architecture perspective, which solution is modular-enough to allow an investment bank to pluck out specific components of a vendor offering that can then be married with existing, in-house built, legacy middle- or back-office systems that are often near-impossible to displace?
